(PRWEB) July 01, 2014
The "Newborn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse-oximeter), Instrument, Accessories, Reagent & by Assay Kit – Global Forecast to 2019" provides a detailed overview of the current market trends and strategies impacting the global market along with the estimates and forecasts of the revenue and share analysis.
Browse 63 market data tables and 13 figures spread through 215 pages and in-depth TOC
Early buyers will receive 10% customization on reports.
The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% between 2013 and 2019.
For Further Inquiries: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=141676244
The report segments this market based on type, technology, product and geography. Among various technologies, the enzyme assays and immunoassays commanded the largest share in 2013, while tandem mass spectrometry is forecasted to be the fastest-growing segment in the newborn screening market. Factors such as benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases are driving the growth of newborn screening market. Furthermore, owing to continuous advancements in technology, new and innovative devices are being launched in the market, which is another major factor providing impetus for growth of the market.
Request for Customization Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=141676244
Based on geography, the global newborn screening market is segmented into North America, South America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the government support in terms of formation of legislation, grants and funding, need for reducing healthcare cost and rising awareness.
The prominent players in the newborn screening market are AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).
Browse Related Reports:
High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog: http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets